Context This overview presents the updated European Association of Urology (EAU)
guidelines for muscle-invasive and metastatic bladder cancer (MMIBC). Objective To provide …

Background Long-term hormone therapy has been the standard of care for advanced prostate
cancer since the 1940s. STAMPEDE is a randomised controlled trial using a multiarm, …

Context Treatment of metastatic urothelial carcinoma is currently undergoing a rapid
evolution. Objective This overview presents the updated European Association of Urology (EAU) …

Background One of the standard options in the treatment of stage IIIA/N2 non-small-cell lung
cancer is neoadjuvant chemotherapy and surgery. We did a randomised trial to investigate …

PURPOSE For patients with resectable stage IIIA(N2) non–small-cell lung cancer, neoadjuvant
chemotherapy with cisplatin and docetaxel followed by surgery resulted in a 1-year event-…

In November 2011, the Third European Consensus Conference on Diagnosis and Treatment
of Germ-Cell Cancer (GCC) was held in Berlin, Germany. This third conference followed …

This Seminar presents the current best practice for the diagnosis and management of bladder
cancer. The scope of this Seminar ranges from current challenges in pathology, such as …

PURPOSE Previous studies suggested that serum levels of microRNA (miR)-371a-3p (so-called
M371 test) have a much higher sensitivity and specificity than the classic markers of …

Background Postoperative hemithoracic radiotherapy has been used to treat malignant
pleural mesothelioma, but it has not been assessed in a randomised trial. We assessed high-…

PURPOSE The classification of the International Germ-Cell Cancer Collaborative Group (IGCCCG)
has been a major advance in the management of germ-cell tumors, but relies on data …